M. Yaqub

发表

Periprocedural Myocardial Infarction in a Randomized Trial of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents: Frequency and Impact on Mortality According to Historic Versus Universal Definitions

G. Stone, D. Kereiakes, D. Cutlip, 2012, Circulation. Cardiovascular interventions.

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.

G. Stone, A. Lansky, J. Hermiller, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.

G. Stone, A. Lansky, J. Hermiller, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial).

G. Stone, A. Lansky, V. Ng, 2011, The American journal of cardiology.

Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years.

G. Stone, A. Lansky, J. Hermiller, 2012, The American journal of cardiology.

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

G. Stone, D. Kereiakes, D. Cutlip, 2010, Journal of the American College of Cardiology.

Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials.

G. Stone, J. E. Maddux, J. Hermiller, 2011, Journal of interventional cardiology.

Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).

G. Stone, A. Lansky, D. Cutlip, 2011, The American journal of cardiology.

Low stent thrombosis risk with the XIENCE V® Everolimus-Eluting Coronary Stent: evidence from randomized and single-arm clinical trials.

A. Lansky, J. Hermiller, P. Sood, 2011, Journal of interventional cardiology.

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents.

G. Stone, J. Hermiller, R. Applegate, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De

G. Stone, A. Lansky, D. Kereiakes, 2010, JACC. Cardiovascular interventions.

Everolimus Eluting Coronary Stent System in the Treatment of ubjects With De Novo Native Coronary Artery Lesions ) Randomized Trials

G. Stone, J. Hermiller, K. Sudhir, 2022 .

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.

G. Stone, J. Hermiller, R. Applegate, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.

G. Stone, A. Lansky, D. Kereiakes, 2013, The American journal of cardiology.

Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study

M. Wei, N. Gutiérrez, L. Ysebaert, 2021, Blood.